Two Sigma Securities’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADCT
ACM
OM
Two Sigma Securities's ADCT Position: Q3 2026 in Review
Two Sigma Securities opened a new position in ADC Therapeutics (ADCT) in Q3 2026: 13,578 shares worth $16.6K. The stake represents ﹤0.01% of the portfolio and ranks #1522 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in ADCT as recently as Q4 2024.
Two Sigma Securities first reported a position in ADCT in Q4 2024 and has held it in 2 quarters since. The position peaked at $29.9K in Q4 2024. 110 funds tracked by Wall St. Rank hold ADCT as of Q3 2026.
- Two Sigma Securities held 13,578 shares of ADC Therapeutics worth $16.6K as of Q3 2026.
- ADC Therapeutics was a new Two Sigma Securities position in Q3 2026.
- ADC Therapeutics made up ﹤0.01% of Two Sigma Securities's portfolio in Q3 2026, its #1522 holding.
- Two Sigma Securities first reported a position in ADC Therapeutics in Q4 2024 and has held it in 2 quarters since.
- Two Sigma Securities's ADC Therapeutics position peaked at $29.9K in Q4 2024.
- 110 funds tracked by Wall St. Rank held ADC Therapeutics as of Q3 2026.
Based on Two Sigma Securities's 13F filing for Q3 2026, filed 16 Nov 2026.